This course provides an insight into the role of personalised cancer profiling in cellular pathology. The content covers the principles and techniques involved in preparing FFPE tissue samples for genetic sequencing, a basic overview of the NGS process and analysis of the results. It also provides an insight into how the identification of significant genomic alterations, within an individual’s tumour, can provide oncologists with alternative targeted drug therapy options
Die Britse NEQAS Sellulêre Patologietegniek word bedryf deur LabXCell Bpk., 'n niewinsgewende maatskappy wat in Engeland en Wallis geregistreer is (Maatskappynommer 5311646).
